Αποτελέσματα Αναζήτησης
15 Αυγ 2022 · IR of major amputations was 94.82 (95% CI 56.62–158.80) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 100.76 (95% CI 53.71–189.01) and among type 2 diabetes was 40.58 (95% CI 11.03–149.28).
- Diabetic foot disease and the risk of major clinical outcomes
Characterizing the burden of diabetic foot disease (DFD) can...
- Diabetic foot disease and the risk of major clinical outcomes
25 Ιουν 2020 · The most severe form of PAD is termed chronic limb-threatening ischemia and carries a significant risk of limb loss and cardiovascular mortality. Diabetes mellitus is known to increase the incidence of PAD, accelerate disease progression, and increase disease severity.
1 Δεκ 2022 · IR of major amputations was 94.82 (95% CI 56.62–158.80) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 100.76 (95% CI 53.71–189.01) and among type 2 diabetes ...
19 Απρ 2023 · Characterizing the burden of diabetic foot disease (DFD) can enhance the prevention and management of foot complications, which may reduce rates of amputation. It is widely believed that 15–25% of people with diabetes will develop DFD during their lifetime [3] .
High mortality rates have been reported after major amputations of a lower limb secondary to diabetes and peripheral vascular disease. However, the mortality rates have varied across studies. A systematic review of the 5-year mortality after nontraumatic major amputations of the lower extremity was conducted.
21 Απρ 2023 · The influence of diabetes mellitus (DM) on mortality following lower extremity amputation (LEA) remains controversial. This systematic review and meta-analysis aimed to determine the influence of DM on long-term mortality (LTM) and short-term mortality (STM) after amputation.
The rate varied widely by HRR (1.2 per 1,000 to 6.2 per 1,000), with higher variation in amputation rates in black patients (2.1 to 16.1 per 1,000). Overall, amputation-free survival was approximately 74.6% at 2 years, 68.4% among black patients and 75.4% among non-black patients, with the disparity between the 2 groups increasing over time.
